Jazz Pharmaceuticals plc 4

Bruce C. Cozadd sold 6,000 Ordinary Shares of Jazz Pharmaceuticals plc at about $240.47 per share under a Rule 10b5‑1 plan.

On July 1, 2026, Bruce C. Cozadd, an insider of Jazz Pharmaceuticals plc, sold 6,000 Ordinary Shares at an average price of approximately $240.47 per share, for total proceeds of about $1.44 million, under a pre-arranged Rule 10b5-1 trading plan adopted on November 26, 2025. Following this automatic, non‑discretionary sale, Cozadd’s direct ownership in Jazz Pharmaceuticals stands at 366,682 Ordinary Shares, representing a substantial continuing equity stake in the company. The transaction appears to be a significant but structured diversification sale rather than an opportunistic trade, given its execution under the 10b5‑1 plan.

Filing Facts

CIK

1232524

Ticker

JAZZ

Form

4

Source Type

sec

Accession

0001193210-26-000016

Alert Tier

7